OGI "Mighty Mouse" of Cannabis SpaceWhile the following article (link) concerns 3 Cannabis companies considered to be overvalued, the commentary on OGI is very positive. OGI is still very much an unknown quantity in terms of analyst coverage.
"Personally, I think there's a lot to like about OrganiGram, although I wouldn't count on a 167% return every five months. This is a company with one of the highest yields per square foot in the industry, with management calling for 113,000 kilos of annual output across roughly 490,000 square feet of cultivation space. At more better than 230 grams per square foot, OrganiGram is producing at more than double the industry average yield. OrganiGram is also bound to make noise with its push into derivatives, such as edibles and beverages. Derivatives boast considerably higher margins than traditional dried cannabis, making them perfect for companies looking to lift their gross and operating margins. OrganiGram, for its part, has blatantly said that it's looking for a beverage partner, and I'd be surprised if it didn't soon find one.
Though Wall Street's price target suggests selling, I wouldn't dare suggest giving up on this Mighty Mouse of the cannabis space."
https://finance.yahoo.com/news/3-marijuana-stocks-wall-street-103600437.html